SimplePractice Private Equity Ownership: What It Means

Who Actually Owns SimplePractice Now

When you choose an EHR, you are not just choosing software. You are choosing who holds the most sensitive record a therapy practice ever creates — and, by extension, who that record answers to. That second choice is easy to overlook, because the owner sits behind the login screen. But owners change. SimplePractice's did.

If you searched "SimplePractice private equity" or "who owns SimplePractice," here is the documented chain, stated up front and sourced below. SimplePractice was founded in 2012 and later became the "Health & Wellness" vertical of a parent company, EngageSmart. In October 2023, EngageSmart agreed to be taken private by Vista Equity Partners, a private-equity firm, in a deal valuing the company at approximately $4.0 billion. The deal closed in January 2024 (Vista Equity Partners press release, Oct 23, 2023). SimplePractice is now owned, through EngageSmart, by a private-equity firm.

This piece does three things, in order: it lays out the documented ownership history with dates; it explains, as clearly labeled industry-pattern commentary, what private-equity ownership of clinical software tends to mean; and it walks through the specific, sourced changes SimplePractice has actually made — pricing, an AI add-on, and a new transcript-retention policy — so you can judge the patterns against the facts. We close with the "acquisition loophole" and how to think about your own data and pricing risk. Everything here is general information, not legal or financial advice.

The Documented Ownership History

SimplePractice's origins and parent company

SimplePractice was founded in 2012 and is headquartered in Santa Monica, California; company profiles credit founders Howard Spector and Ken Braslow (corroborated across company profiles such as Tracxn and Built In; treat year and founders as solid background). What matters for ownership is what happened above SimplePractice at the holding-company level.

Per Summit Partners' own company page, Summit Partners has backed the business since 2015. General Atlantic announced a strategic partnership with the payments company Invoice Cloud in December 2018, becoming its majority shareholder alongside existing investor Summit Partners (General Atlantic). The holding company was later rebranded EngageSmart in 2020, with SimplePractice positioned as its Health & Wellness vertical (Summit Partners). In other words, SimplePractice has sat inside an investor-backed holding structure for years; the 2024 Vista deal is the most recent change of control, not the first time outside capital has owned it.

The 2021 IPO

EngageSmart's shares began trading on the New York Stock Exchange under the ticker ESMT on September 23, 2021, and the IPO closed on September 27, 2021, with the company issuing and selling 13,620,054 shares at $26.00 each for roughly $326.4 million in net proceeds (EngageSmart S-1/A and subsequent 10-Q via SEC EDGAR, CIK 1863105). For about two years, EngageSmart traded as a public company — which means its pricing levers, customer counts, and strategy were disclosed in filings.

The Vista Equity Partners take-private (the change of control)

In early October 2023, reports surfaced that General Atlantic was exploring a sale of EngageSmart roughly two years after the IPO (Tech Startups, Oct 5, 2023). Three weeks later it was official.

On October 23, 2023, EngageSmart agreed to be acquired by Vista Equity Partners for $23.00 per share in cash, valuing the company at approximately $4.0 billion. That price was a 23% premium to EngageSmart's unaffected closing price of $18.71 on October 4, 2023, and roughly a 30% premium to the 30-day volume-weighted average price (Vista Equity Partners press release, Oct 23, 2023). The same release states that, after closing, affiliates of Vista hold approximately 65% and affiliates of General Atlantic hold approximately 35% of EngageSmart.

EngageSmart stockholders approved the transaction at a special meeting on January 23, 2024, and the acquisition was completed in January 2024, with EngageSmart's common stock ceasing to trade and delisting from the NYSE (Vista Equity Partners completion announcement, Jan 26, 2024). EngageSmart's brands include SimplePractice, InvoiceCloud, and DonorDrive, and as of June 30, 2023 the company reported 109,700 SMB and 3,400 enterprise customers (Vista press release, Oct 23, 2023).

The fact to carry forward: SimplePractice is now privately held by a private-equity firm, after a clean, documented change of control completed in early 2024.

What Private-Equity Ownership Tends to Mean

The rest of this section is commentary — the general private-equity software playbook, not a set of accusations about SimplePractice. Whether each pattern applies is something you should evaluate against the specific, sourced SimplePractice changes in the next section. We are deliberately separating "this is how the model usually works" from "this is what SimplePractice did."

The structural mandate is return to outside investors on a clock. (Commentary.) Private-equity funds are finite-life vehicles. The firm raises capital, deploys it, and is expected to return it — typically over a holding period of roughly three to seven years — before exiting via a sale or re-IPO. That clock shapes incentives in a way a founder-owned or publicly traded company's do not. The practicing therapist Robin Levick (LMFT, CA #88545), reading his own EHR's contract, put the structural point bluntly in his April 2026 essay, calling Vista "not a healthcare company. It is a data company" (robinlevick.com). That is his named opinion, not an adjudicated fact, and we flag it as such — but the underlying structural observation, that a private-equity owner is obligated to grow value before an exit, is uncontroversial.

The common levers are well known. (Commentary.) To grow value on that clock, software roll-ups typically pull some combination of: raising list prices; unbundling features that used to be included into separately priced add-ons; improving per-transaction or processing economics; and treating accumulated data as an asset to be grown and, where regulation allows, monetized before an exit.

The "data-as-asset" idea deserves a caveat. (Commentary, grounded in facts below.) In regulated health software, a large clinical corpus has real strategic value — for analytics, for product features, and as training material for AI. We are not asserting that SimplePractice does any specific thing with your data here. We are saying the incentive exists, and the only honest way to evaluate it is against the company's own documented terms and policies — which is exactly what the next section does.

What Actually Changed at SimplePractice

This is the spine of the article: only sourced, dated, SimplePractice-specific changes. No motives are assigned. Each item is a fact you can check.

1. A 2025 pricing restructure

SimplePractice restructured its plans effective on the billing date on or after March 3, 2025, per SimplePractice's own "New Packages & Pricing FAQs" (distributed via an American Psychological Association member pricing document). The tiers became Starter $49/month, Essential $79/month, and Plus $99/month, with per-clinician seats at $74 (2–5 clinicians), $72 (6–15), and $69 (16+). The Starter plan was previously $29/month, so the base entry tier roughly doubled. We have a full cost-stack breakdown — including the AI add-on, card-processing fees, and per-clinician seats — in our companion piece, SimplePractice Pricing in 2026. For the card-processing rate specifically, confirm the current figure on SimplePractice's own pricing/payments page before relying on it, as processor rates change.

2. AI monetized as a separate add-on

SimplePractice's AI Note Taker is an optional add-on at $35/month per enabled clinician after a 30-day free trial, and it is powered by Anthropic's Claude. Per SimplePractice's own support pages, Note Taker works for both in-person and telehealth sessions: for in-person visits, the clinician records audio through the SimplePractice for Clinicians mobile app, and for video visits it works through SimplePractice's own Telehealth — not through Zoom, Doxy.me, Google Meet, or other external video tools (SimplePractice: "Using Note Taker during in-person sessions" and "Using Note Taker with telehealth"). SimplePractice's AI Note Taker feature page also states that its AI tools meet HIPAA standards "verified through HITRUST certification" (SimplePractice feature page). We report that as SimplePractice's own claim about itself; we make no SOC 2 claim about anyone.

3. A new transcript-retention policy

This is the newsworthy specific. Per SimplePractice's Transcript Retention FAQ, session recordings are deleted immediately after transcription, and transcripts are retained for the shorter of 7 days or until the note is signed and locked.

Then comes the change. Starting June 16, 2026, SimplePractice may retain a "de-identified and de-coupled" version of a Note Taker transcript "to help continue improving Note Taker and other AI-powered features." The default behavior depends on timing: clinicians who used Note Taker before June 16, 2026 are opted out by default, while clinicians enabling it on or after June 16, 2026 are opted in by default, with the ability to opt out at the clinician, client, or session level. SimplePractice states that retained transcripts "will be used only to improve our AI features and will never be shared with third parties for their commercial purposes" (SimplePractice Transcript Retention FAQ).

We present this precisely and we do not embellish it. SimplePractice does not say it sells your transcripts, and we do not claim it does. The documented facts are the retention window, the June 16, 2026 effective date, the de-identified/de-coupled language, and the opt-in/opt-out defaults — and those are strong enough to think carefully about on their own.

4. The 2023 terms-of-service change (context, pre-Vista)

In August 2023 — before the Vista deal was announced — SimplePractice updated its terms to add a broad User Data license, described as "non-exclusive, worldwide, royalty-free, fully paid-up, perpetual, irrevocable, sublicensable (through multiple tiers), and transferable," and stated to continue applying "even after the expiration or termination of the user's account." The update also added a binding-arbitration and class-action waiver (effective August 2, 2023, per Paubox's analysis, which quotes the terms verbatim, and corroborated by Levick). After a short acceptance window and customer backlash, the deadline was extended to September 1, 2023 (zynnyme).

Levick's timing observation — that the license was expanded roughly two months before the acquisition announcement — is presented here as his labeled commentary, not as a finding.

5. Tracking-pixel allegations (allegation, not finding)

Separately, plaintiff-side attorneys working with ClassAction.org (distinct from Levick, who is a clinician, not a lawyer) have alleged that SimplePractice embedded tracking pixels from Meta, Google, and TikTok in the client portal where clients booked appointments and filled out intake forms. We present this strictly as an unadjudicated allegation: no court ruling establishing it was found, and we are not asserting it as fact (robinlevick.com).

The Acquisition Loophole: What Happens to Your Data and Pricing Under New Owners

Here the facts and the analysis sit side by side, so we label each.

Fact (anchor). SimplePractice's own 2023 terms grant a User Data license that is "transferable" and "sublicensable" and that continues after the expiration or termination of your account (Paubox, quoting the terms). A transferable license is, by definition, a right that can move with the company in a sale. New owners inherit the data and the license terms.

Commentary. A privacy promise is only as durable as the contract that binds the next owner. A friendly policy written by today's management can be amended by tomorrow's owner — unless the commitment is drafted to bind "successors and assigns." That gap is the acquisition loophole: the place where many privacy promises quietly expire, not through any dramatic betrayal, but through an ordinary change of control followed by an ordinary policy update.

Fact (practical). In a therapy practice, you and your clients are the data subjects, but the EHR holds the corpus, and switching costs are real once you are in. The leverage sits with whoever owns the platform.

General information, not legal advice. The defensible move for any therapist is to read the documents directly: your EHR's current terms of service, your BAA, and its AI and transcript policies — and to check the effective dates on each. Promises made on a marketing page are not the same as obligations written into a contract that survives a sale.

How CoralEHR Approaches This Differently

We mention CoralEHR once, and we keep the claims narrow.

CoralEHR runs on HIPAA-compliant infrastructure and signs a Business Associate Agreement with every account. Its AI only drafts — note drafts come from a short typed scratchpad, the clinician reviews and signs every note, and nothing is auto-signed. CoralEHR uses Anthropic's first-party API, and patient data trains nothing (CoralEHR product pages and the No AI Therapist Pledge). We make no SOC 2 claim here.

On the loophole specifically, CoralEHR's pledge addresses it in writing, verbatim:

"These commitments survive a change of control. They bind us, our successors, and our assigns. If CoralEHR is ever acquired or merged, this pledge goes with it. The acquisition loophole is where most privacy promises quietly die. We are closing it on purpose."

We are careful not to overclaim. That language does not promise CoralEHR will never be acquired, and it does not promise prices will never change. It is the narrow commitment that the data and AI promises are written to bind whoever owns the company next. On pricing, CoralEHR's current plans are Starter $29/month and Professional $79/month, with no CoralEHR platform markup on card processing (processor and card-network fees may still apply). For a feature-by-feature comparison, see SimplePractice vs CoralEHR.

Conclusion: Evaluate the Owner, Not Just the Interface

Here is the through-line. The ownership chain is documented: SimplePractice sits inside EngageSmart, which Vista Equity Partners took private for roughly $4.0 billion in a deal announced in October 2023 and completed in January 2024. The private-equity playbook — finite fund clocks, price increases, feature unbundling, data as an asset — is real industry-pattern commentary, and the honest test is to check it against facts. The facts are SimplePractice's own documented changes: the 2025 pricing restructure, the $35/month AI Note Taker, and the June 16, 2026 transcript-retention update, all stated precisely and none exaggerated. And the acquisition loophole is the reason any of this matters to you: privacy promises bind only the current owner unless they are written to bind the next one.

So evaluate any EHR the way you would evaluate a long-term partner: ask who owns it, and ask what its terms of service and BAA say survives a sale. The interface is what you fall in love with. The contract is what you actually get.

---

Keep Reading

• The No AI Therapist Pledge — CoralEHR's change-of-control commitment, in writing
• SimplePractice vs CoralEHR — Feature-by-feature comparison
• SimplePractice Pricing in 2026 — The full, sourced cost stack
• SimplePractice Alternatives for Private-Pay Therapy — Six EHRs compared
• SimplePractice Alternatives Hub — Choosing and switching EHRs

This article is general information, not legal or financial advice. Verify SimplePractice's current pricing, terms, and policies on SimplePractice's own pages before making a decision.